We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Mounts Offensive For Eloxatin

Law360 (July 25, 2007, 12:00 AM EDT) -- Eloxatin is once again the subject of heavy litigation now that Sanofi-Aventis U.S. LLC has slammed generics makers with patent infringement suits over the hit colon cancer drug, just days after...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.